- Grant of Options, RSUs and PSUs and PDMR Dealing
- Filing of form 10-K for FY ended December 31, 2023
- Reports Q4 & FY 2023 Financial Results
- MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
- TR-1: Notification of major holdings
- Preliminary FY Results & 2024 Guidance
- MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results
- Total Voting Rights
- Exercise of options and PDMR dealing
- Notice of Results
More ▼
Key statistics
On Thursday, MaxCyte Inc (MXCT:LSE) closed at 342.50, -22.16% below its 52-week high of 440.00, set on Apr 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 345.00 |
---|---|
High | 335.00 |
Low | 335.00 |
Bid | 335.00 |
Offer | 355.00 |
Previous close | 345.00 |
Average volume | 20.74k |
---|---|
Shares outstanding | 104.13m |
Free float | 97.63m |
P/E (TTM) | -- |
Market cap | 436.30m USD |
EPS (TTM) | -0.3636 USD |
Data delayed at least 20 minutes, as of Mar 28 2024 16:18 BST.
More ▼